The first 28 days of life – the neonatal period – is the most vulnerable time for a child’s survival. Children face the highest risk of dying in their first month of life at an average global rate of 17.2 deaths per 1,000 live births in 2024, down by 53 per cent from 36.6 deaths per 1,000 live births in 1990. In comparison, the probability of dying after the first month and before ...
A newborn infant, or neonate, refers to a baby in the first 28 days of life, a period marked by the highest risk of morbidity and mortality. Enhancing neonatal survival and health and preventing avoidable deaths and stillbirths requires achieving high coverage of quality antenatal care, skilled birth attendance, and postnatal care for both mothers and newborns. Neonatal deaths, which occur ...
Preterm babies are at an increased risk of post-neonatal mortality, stunting and long-term neurodevelopmental impairment during childhood. The India Newborn Action Plan (INAP), 2014 outlines strategies to strengthen preterm births and address symptoms and other risk factors.
The Departments of Biochemistry, Neurosciences, and Pharmacology provide an interdisciplinary home for the Master of Science in Biotechnology (MS-Biotech) program. The MS-Biotech program offers a ...
Medical pharmacology can feel overwhelming, but strategic learning methods like spaced repetition and case-based learning can make it stick. By combining real-world clinical scenarios with ...
ascopubs.org: A phase 1a/1b trial in relapsed/refractory T-cell non-Hodgkin lymphoma to determine the safety profile, pharmacology, and maximum tolerated dose of ST-001, an intravenous ...
A phase 1a/1b trial in relapsed/refractory T-cell non-Hodgkin lymphoma to determine the safety profile, pharmacology, and maximum tolerated dose of ST-001, an intravenous ...